Recent Advances in Ocular Pharmacology
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 2231
Special Issue Editors
Interests: pediatric ophthalmology ; strabismus; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Interests: cataract; epigenetics; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ophthalmic drug discovery and development is a dynamic field of research, which draws increasing attention, as novel medications and delivery techniques demonstrate promising results. New therapeutic agents, including pharmaceutical compounds and gene therapy products, overcome the anatomic and physiologic barriers, achieving increasingly satisfactory treatment outcomes. It is vital that eye health professionals are kept up to date with the most recent achievements in this emerging field, thus being able to implement state-of-the-art treatments in their practice.
The aim of this Special Issue is to present current research, clinical trials, and reviews concerning ocular drugs.
Dr. Lampros Lamprogiannis
Prof. Dr. Ioannis Tsinopoulos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmology
- ocular diseases
- drug delivery
- drug targeting
- controlled drug release
- eye drops
- biopolymers
- nanomedicine
- clinical applications
- clinical trials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
